drugset

drugset / Trial / NCT01738815

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

NCT01738815 ↗

Phase 0 Completed 43 enrolled State University of New York - Upstate Medical University

NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to test whether the drug valproic acid can cause changes in bladder tumors that might inhibit their growth.

Timeline

Start: 2011-12
Primary completion: 2013-05
Completion: 2014-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Valproic Acid	Small molecule	500 mg	Oral

Indications